atorvastatin has been researched along with bms201038 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Funatsu, T; Kakuta, H; Miyata, K; Takasu, T | 1 |
| Dutta, S; Foulds, P; King, A; Korb, S; Patel, G; Sumeray, M; Wade, JR | 1 |
1 trial(s) available for atorvastatin and bms201038
| Article | Year |
|---|---|
Evaluation of the effects of the weak CYP3A inhibitors atorvastatin and ethinyl estradiol/norgestimate on lomitapide pharmacokinetics in healthy subjects.
Topics: Adolescent; Adult; Anticholesteremic Agents; Atorvastatin; Benzimidazoles; Contraceptives, Oral, Combined; Cytochrome P-450 CYP3A Inhibitors; Drug Combinations; Drug Interactions; Ethinyl Estradiol; Female; Healthy Volunteers; Humans; Male; Middle Aged; Norgestrel; Young Adult | 2016 |
1 other study(ies) available for atorvastatin and bms201038
| Article | Year |
|---|---|
Atorvastatin increases hepatic fatty acid beta-oxidation in sucrose-fed rats: comparison with an MTP inhibitor.
Topics: Animals; Apolipoproteins B; Atorvastatin; Benzimidazoles; Carrier Proteins; Cholesterol; Fatty Acids; Heptanoic Acids; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lipid Metabolism; Lipoproteins, VLDL; Liver; Male; Oxidation-Reduction; Pyrroles; Rats; Rats, Sprague-Dawley; Sucrose; Triglycerides | 2002 |